Sign Up
bf/AMEX:CLDI_icon.jpeg

COM:CALIDIBIO

Calidi Biotherapeutics

  • Stock

Last Close

2.15

22/11 21:00

Market Cap

37.48M

Beta: -

Volume Today

1.48M

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
average inventory
average payables
442.92K
-
average receivables
book value per share
74.89
-
capex per share
0.07
-
capex to depreciation
1.35
-
capex to operating cash flow
-0.19
-
capex to revenue
0.46
-
cash per share
0.37
-
days of inventory on hand
days payables outstanding
247.89
-
days sales outstanding
debt to assets
0.02
-
debt to equity
0.02
-
dividend yield
earnings yield
0.01
-
enterprise value
286.16M
-
enterprise value over ebitda
-160.61
-
ev to operating cash flow
-264.25
-
ev to sales
637.32
-
free cash flow per share
-0.45
-
free cash flow yield
-0.00
-
graham net net
-5.35
-
graham number
44.55
-
income quality
-0.32
-
intangibles to total assets
0
-
interest coverage
-2.90
-
interest debt per share
2.02
-
inventory turnover
invested capital
1.66M
-
market cap
282.04M
-
net current asset value
-14.97M
-
net debt to ebitda
-2.31
-
net income per share
1.18
-
operating cash flow per share
-0.38
-
payables turnover
1.47
-
receivables turnover
research and ddevelopement to revenue
10.41
-
return on tangible assets
0.01
-
revenue per share
0.16
-
roe
0.02
-
roic
-0.01
-
sales general and administrative to revenue
13.73
-
shareholders equity per share
74.89
-
stock based compensation to revenue
2.96
-
tangible asset value
215.32M
-
tangible book value per share
74.89
-
working capital
1.07M
-

All numbers in (except ratios and percentages)